Investigating New Front-end Features in the SONNET 3

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Cochlear implants help individuals with hearing loss by delivering electrical signals directly to the auditory nerve, bypassing damaged parts of the ear. While they significantly improve speech perception in quiet environments and over the telephone, challenges remain in noisy environments due to interference from background noise. To address this, advancements in signal-processing strategies, microphone technology, and noise-reduction algorithms have been introduced. The focus of the study is on two new front-end features: * Focused Beamformer - Enhances directional hearing. * AI Mode Medium - Utilizes the adaptive intelligence for optimized sound processing.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Minimum age of eighteen (18) years at time of enrolment

• Experienced MED-EL cochlear implant (CI) user (≥ 6 months) for the ear to be tested

• User of a MED-EL Audio Processor (i.e. a SONNET, SONNET 2, SONNET 3, or RONDO 3 ≥ 3months)

• Post-lingual onset of severe to profound sensory-neural hearing loss on the ear to be tested

• A minimum of 40% speech recognition in the Freiburg Monosyllables Test in quiet at 65 dB sound pressure level (SPL) for the ear to be tested (at the last time tested in clinical routine)

• Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure.

Locations
Other Locations
Austria
Medizinische Universität Innsbruck, Universitätsklinik für Hör-, Stimm-, und Sprachstörungen
RECRUITING
Innsbruck
Universitätsklinikum St. Pölten, Abteilung für Hals-, Nasen- und Ohrenerkrankungen
NOT_YET_RECRUITING
Sankt Pölten
Time Frame
Start Date: 2025-09-29
Estimated Completion Date: 2026-09-29
Participants
Target number of participants: 40
Treatments
Experimental: Adult MED-EL Cochlear implant users with post-lingual, severe to profound sensory-neural hearing los
Testing new versus approved front-end features (within subject design)
Related Therapeutic Areas
Sponsors
Collaborators: Universitätsklinikum St. Pölten - NÖ Landeskliniken, Universitätsklinikum für Hals-, Nasen-, Ohrenkrankheiten, Medizinische Universität Innsbruck, Universitätsklinik für Hör-, Stimm-, und Sprachstörungen
Leads: MED-EL Elektromedizinische Geräte GesmbH

This content was sourced from clinicaltrials.gov